Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Buttmann

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Expert Review of Neurotherapeutics|April 28, 2010
Treating multiple sclerosis with monoclonal antibodies: a 2010 updateMathias Buttmann
Expert Review of Neurotherapeutics|March 19, 2008
Treating multiple sclerosis with monoclonal antibodiesMathias Buttmann, Peter Rieckmann
MMW Fortschritte Der Medizin|January 29, 2010
[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis]Mathias Buttmann, Peter Rieckmann
Expert Review of Neurotherapeutics|March 8, 2007
Interferon-beta1b in multiple sclerosisMathias Buttmann, Peter Rieckmann
Journal of Neuroimmunology|October 7, 2004
Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosisMathias Buttmann, Cornelia Merzyn, Peter Rieckmann
Trends in Pharmacological Sciences|June 25, 2013
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disordersMathias Buttmann, Srini Kaveri, Hans-Peter Hartung
Acta Neuropathologica Communications|June 3, 2014
Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomographyJanos Groh, David Stadler, Mathias Buttmann, et al.
International Journal of Molecular Sciences|August 20, 2015
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial CellsAxel Haarmann, Mathias Nehen, Annika Deiß, et al.
Journal of the Neurological Sciences|July 29, 2010
Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090QNico Melzer, Joseph Classen, Karlheinz Reiners, et al.
Expert Review of Neurotherapeutics|March 2, 2013
Treating multiple sclerosis with monoclonal antibodies: a 2013 updateAnnika Deiß, Isabel Brecht, Axel Haarmann, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Expert Review of Neurotherapeutics|April 28, 2010
Treating multiple sclerosis with monoclonal antibodies: a 2010 updateMathias Buttmann
Expert Review of Neurotherapeutics|March 19, 2008
Treating multiple sclerosis with monoclonal antibodiesMathias Buttmann, Peter Rieckmann
MMW Fortschritte Der Medizin|January 29, 2010
[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis]Mathias Buttmann, Peter Rieckmann
Expert Review of Neurotherapeutics|March 8, 2007
Interferon-beta1b in multiple sclerosisMathias Buttmann, Peter Rieckmann
Journal of Neuroimmunology|October 7, 2004
Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosisMathias Buttmann, Cornelia Merzyn, Peter Rieckmann
Trends in Pharmacological Sciences|June 25, 2013
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disordersMathias Buttmann, Srini Kaveri, Hans-Peter Hartung
Acta Neuropathologica Communications|June 3, 2014
Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomographyJanos Groh, David Stadler, Mathias Buttmann, et al.
International Journal of Molecular Sciences|August 20, 2015
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial CellsAxel Haarmann, Mathias Nehen, Annika Deiß, et al.
Journal of the Neurological Sciences|July 29, 2010
Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090QNico Melzer, Joseph Classen, Karlheinz Reiners, et al.
Expert Review of Neurotherapeutics|March 2, 2013
Treating multiple sclerosis with monoclonal antibodies: a 2013 updateAnnika Deiß, Isabel Brecht, Axel Haarmann, et al.
Pageof 6